Basit öğe kaydını göster

dc.contributor.authorEkici, Yeliz
dc.contributor.authorYilmaz, Abdullah
dc.contributor.authorKucuksezer, Umut Can
dc.contributor.authorGazioglu, Sema Bilgic
dc.contributor.authorYamalioglu, Zeynep Dogusan
dc.contributor.authorGurol, Ali Osman
dc.contributor.authorLinn, Thomas
dc.contributor.authorTuncer, Feyza Nur
dc.date.accessioned2021-12-21T08:46:52Z
dc.date.available2021-12-21T08:46:52Z
dc.date.issued2021
dc.identifier.issn1357-0560
dc.identifier.issn1559-131X
dc.identifier.urihttps://doi.org/10.1007/s12032-021-01560-4
dc.identifier.urihttp://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2115
dc.description.abstractPancreatic ductal adenocarcinoma (PDAC) is among the most deadly cancers. Since most patients develop resistance to conventional treatments, new approaches are in urgency. Valproic acid (VPA) was shown to induce apoptosis and reduce proliferation in PANC-
dc.description.sponsorshipScientific Research Projects Coordination Unit of Istanbul UniversityIstanbul University [32763]
dc.language.isoEnglish
dc.publisherHumana Press Inc
dc.titleCombined evaluation of proliferation and apoptosis to calculate IC50 of VPA-induced PANC-1 cells and assessing its effect on the Wnt signaling pathway
dc.typeArticle
dc.relation.journalMedıcal Oncology
dc.identifier.issue9
dc.identifier.volume38
dc.identifier.doi10.1007/s12032-021-01560-4
dc.relation.issue9
dc.relation.volume38


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster